Growth factors and cancer.

Signaling pathways that mediate the normal functions of growth factors are commonly subverted in cancer. Oncogenes identified by a variety of approaches have been shown to function at critical steps in mitogenic signaling. Progression through the cell cycle requires the coordinated actions of members of two complementary classes of growth factors, and oncogenes appear to replace the actions of one set of these growth factors. Growth factors can also influence normal cell differentiation, and constitutive activation of growth-promoting pathways in cancer cells can modulate the cell phenotype as well. Paracrine actions of growth factors and cytokines may also influence the stepwise series of genetic events that lead to malignancy. New approaches for cancer therapy are being developed that intervene at various steps in growth factor signaling pathways.

[1]  A. Ogura,et al.  Sarcoma viruses carrying ras oncogenes induce differentiation-associated properties in a neuronal cell line , 1985, Nature.

[2]  T. Pawson,et al.  Interactions of phosphatidylinositol kinase, GTPase-activating protein (GAP), and GAP-associated proteins with the colony-stimulating factor 1 receptor , 1990, Molecular and cellular biology.

[3]  T. Jessell,et al.  Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation. , 1989, Science.

[4]  P. Comoglio,et al.  c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase. , 1991, Oncogene.

[5]  J. Schlessinger,et al.  Signal transduction through the EGF receptor transfected in IL-3-dependent hematopoietic cells. , 1988, Science.

[6]  T. Pollard,et al.  Regulation of phospholipase C-gamma 1 by profilin and tyrosine phosphorylation. , 1991, Science.

[7]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[8]  Christopher T Denny,et al.  Leukemia and the disruption of normal hematopoiesis , 1991, Cell.

[9]  Charles J. Sherr,et al.  The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF 1 , 1985, Cell.

[10]  Stephen H. Friend,et al.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma , 1986, Nature.

[11]  Hermona Soreq,et al.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin , 1985, Nature.

[12]  C. Molloy,et al.  The erbB-2 mitogenic signaling pathway: tyrosine phosphorylation of phospholipase C-gamma and GTPase-activating protein does not correlate with erbB-2 mitogenic potency , 1991, Molecular and cellular biology.

[13]  G. Inghirami,et al.  Transformation and plasmacytoid differentiation of EBV-infected human B lymphoblasts by ras oncogenes. , 1989, Science.

[14]  S. Heinemann,et al.  Cholinergic metabolism and synapse formation by a rat nerve cell line. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J B Gibbs,et al.  Modulation of guanine nucleotides bound to Ras in NIH3T3 cells by oncogenes, growth factors, and the GTPase activating protein (GAP). , 1990, The Journal of biological chemistry.

[16]  R. Levi‐montalcini,et al.  The nerve growth factor 35 years later. , 1987, Science.

[17]  K. Semba,et al.  A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Parsons,et al.  Transformation by pp60src or stimulation of cells with epidermal growth factor induces the stable association of tyrosine-phosphorylated cellular proteins with GTPase-activating protein , 1991, Molecular and cellular biology.

[19]  T. Hirano,et al.  Molecular cloning and expression of an IL-6 signal transducer, gp130 , 1990, Cell.

[20]  M. Hayman,et al.  Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Aaronson,et al.  Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes. , 1989, Science.

[22]  P. Casey,et al.  Inhibition of purified p21 ras farnesyl:protein transferase by Cys-AAX tetrapeptides , 1990, Cell.

[23]  M. Ittmann,et al.  An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family , 1987, Cell.

[24]  T. Matsui,et al.  FGF modulates the PDGF-driven pathway of oligodendrocyte development , 1990, Neuron.

[25]  M. Brann,et al.  Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[26]  S. Courtneidge,et al.  An 81 kd protein complexed with middle T antigen and pp60c-src : A possible phosphatidylinositol kinase , 1987, Cell.

[27]  T. Hunter,et al.  Transforming gene product of Rous sarcoma virus phosphorylates tyrosine , 1980, Proceedings of the National Academy of Sciences.

[28]  J. Bishop,et al.  The product of the protooncogene c-src is modified during the cellular response to platelet-derived growth factor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Erikson,et al.  Protein kinase activity associated with the avian sarcoma virus src gene product. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[30]  S. Larson,et al.  Clinical Use of a Monoclonal Antibody to Bombesin‐like Peptide in Patients with Lung Cancer a, b , 1988, Annals of the New York Academy of Sciences.

[31]  R. Kumar,et al.  Regulation of phosphorylation of the c-erbB-2/HER2 gene product by a monoclonal antibody and serum growth factor(s) in human mammary carcinoma cells , 1991, Molecular and cellular biology.

[32]  A. Wolfman,et al.  A cytosolic protein catalyzes the release of GDP from p21ras. , 1990, Science.

[33]  E. Gherardi,et al.  Hepatocytes and scatter factor , 1990, Nature.

[34]  D. Burstein,et al.  Activated N‐ras gene induces neuronal differentiation of PC12 rat pheochromocytoma cells , 1986, Journal of cellular physiology.

[35]  M. Ruggiero,et al.  Macrophage-colony-stimulating factor (CSF-1) induces proliferation, chemotaxis, and reversible monocytic differentiation in myeloid progenitor cells transfected with the human c-fms/CSF-1 receptor cDNA. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J. Bishop Molecular themes in oncogenesis , 1991, Cell.

[37]  D. Golde,et al.  Treatment of hairy-cell leukemia. , 1990, Blood reviews.

[38]  L. Lazarus,et al.  Therapeutic efficacy of the somatostatin analog SMS 201-995 (octreotide) in acromegaly. Effects of dose and frequency and long-term safety. , 1990, Annals of internal medicine.

[39]  D. Smith,et al.  The v-sea oncogene of avian erythroblastosis retrovirus S13: another member of the protein-tyrosine kinase gene family. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[40]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.

[41]  A. Schally Oncological applications of somatostatin analogues. , 1988, Cancer research.

[42]  P. H. Seeburg,et al.  Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes , 1985, Nature.

[43]  A. Levine,et al.  The p53 tumour suppressor gene , 1991, Nature.

[44]  R. Weinberg,et al.  Malignant transformation of mouse primary keratinocytes by Harvey sarcoma virus and its modulation by surrounding normal cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Pike,et al.  Increased cell division as a cause of human cancer. , 1990, Cancer research.

[46]  T. Fleming,et al.  PDGF induction of tyrosine phosphorylation of GTPase activating protein , 1989, Nature.

[47]  J. L. Bos,et al.  ras oncogenes in human cancer: a review. , 1989, Cancer research.

[48]  A. Ullrich,et al.  Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases , 1991, Cell.

[49]  M. Kraus,et al.  Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[50]  D. Spandidos,et al.  Rodent fibroblast tumours expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression. , 1987, British Journal of Cancer.

[51]  A. Ullrich,et al.  Ligand activation of overexpressed epidermal growth factor receptors transforms NIH 3T3 mouse fibroblasts. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[52]  G. Carpenter,et al.  EPIDERMAL GROWTH FACTOR * , 1982, The Journal of biological chemistry.

[53]  D. Lowy,et al.  Suppression of c-ras transformation by GTPase-activating protein , 1990, Nature.

[54]  M J Bissell,et al.  The embryonic environment strongly attenuates v-src oncogenesis in mesenchymal and epithelial tissues, but not in endothelia , 1990, The Journal of cell biology.

[55]  H. Moses,et al.  Regulation of epithelial proliferation by TGF-beta. , 1991, Ciba Foundation symposium.

[56]  A. Ullrich,et al.  Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells , 1987, Cell.

[57]  P. Barr,et al.  Acidic and basic fibroblast growth factors stimulate tyrosine kinase activity in vivo. , 1988, The Journal of biological chemistry.

[58]  Cori Bargmann,et al.  Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185 , 1986, Cell.

[59]  Nic Jones,et al.  Transcriptional regulation by dimerization: Two sides to an incestuous relationship , 1990, Cell.

[60]  L. Liotta,et al.  Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.

[61]  M. Barbacid,et al.  A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences , 1986, Nature.

[62]  S. Cannistra,et al.  Signal transduction of the human granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors involves tyrosine phosphorylation of a common set of cytoplasmic proteins. , 1990, Blood.

[63]  T. Waldmann,et al.  Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[64]  G. Cunha,et al.  Stromal regulation of epithelial function. , 1991, Cancer treatment and research.

[65]  E. Pasquale A distinctive family of embryonic protein-tyrosine kinase receptors. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[66]  J. Ihle,et al.  Stimulation of factor-dependent myeloid cell lines with interleukin 3 induces tyrosine phosphorylation of several cellular substrates. , 1988, The Journal of biological chemistry.

[67]  Teruhiko Yoshida,et al.  K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[68]  T. Fleming,et al.  Autocrine interaction between TGF alpha and the EGF-receptor: quantitative requirements for induction of the malignant phenotype. , 1989, Oncogene.

[69]  H. Kung,et al.  Purification of a factor capable of stimulating the guanine nucleotide exchange reaction of ras proteins and its effect on ras-related small molecular mass G proteins. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[70]  T. Fleming,et al.  Autocrine mechanism for v-sis transformation requires cell surface localization of internally activated growth factor receptors. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[71]  G. Carpenter,et al.  Epidermal Growth Factor , 2002 .

[72]  Frank McCormick,et al.  ras GTPase activating protein: Signal transmitter and signal terminator , 1989, Cell.

[73]  Tony Hunter,et al.  Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity , 1991, Cell.

[74]  W. Pledger,et al.  Epidermal growth factor (EGF) is required only during the traverse of early G1 in PDGF stimulated density-arrested BALB/c-3T3 cells. , 1983, Experimental cell research.

[75]  A. Balmain,et al.  Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene , 1983, Nature.

[76]  S. Lamberts,et al.  Potential role of somatostatin analogues in the treatment of cancer , 1987, European journal of clinical investigation.

[77]  L. Cantley,et al.  Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation , 1985, Nature.

[78]  W Godolphin,et al.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.

[79]  A. Ullrich,et al.  Growth factor receptor tyrosine kinases. , 1988, Annual review of biochemistry.

[80]  T. Hunter,et al.  Phospholipase C-γ is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro , 1989, Cell.

[81]  G. Panayotou,et al.  Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase , 1991, Cell.

[82]  A. Levitzki,et al.  Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors , 1988, Science.

[83]  G. Michalopoulos,et al.  Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes. , 1989, Cancer research.

[84]  A. Balmain,et al.  Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter , 1990, Cell.

[85]  J. Rubin,et al.  Characterization of the receptor for keratinocyte growth factor. Evidence for multiple fibroblast growth factor receptors. , 1990, The Journal of biological chemistry.

[86]  A. Ullrich,et al.  Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences , 1984, Nature.

[87]  G. Carpenter,et al.  Increase of the catalytic activity of phospholipase C-gamma 1 by tyrosine phosphorylation. , 1990, Science.

[88]  M. Montminy,et al.  Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133 , 1989, Cell.

[89]  R. Gallo,et al.  Human T-lymphotropic retroviruses , 1985, Nature.

[90]  P. Nowell,et al.  BCL2-mediated tumorigenicity of a human T-lymphoid cell line: synergy with MYC and inhibition by BCL2 antisense. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[91]  M. Okigaki,et al.  Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. , 1989, Biochemical and biophysical research communications.

[92]  N. Nomura,et al.  High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. , 1986, Cancer research.

[93]  C R King,et al.  Amplification of a novel v-erbB-related gene in a human mammary carcinoma. , 1985, Science.

[94]  W. Lee,et al.  Human retinoblastoma susceptibility gene: cloning, identification, and sequence , 1987, Science.

[95]  L. Greene,et al.  Nerve growth factor-induced increase in electrical excitability and acetylcholine sensitivity of a rat pheochromocytoma cell line , 1977, Nature.

[96]  R. Schreiber,et al.  Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death , 1990, Nature.

[97]  S. Alemà,et al.  Differentiation of PC12 phaeochromocytoma cells induced by v-src oncogene , 1985, Nature.

[98]  S. Hirono,et al.  Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. , 1988, The Journal of clinical investigation.

[99]  David L. Vaux,et al.  Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.

[100]  H. Kung,et al.  Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein , 1984, Nature.

[101]  B. Ames,et al.  Too many rodent carcinogens: mitogenesis increases mutagenesis. , 1990, Science.

[102]  W. Richardson,et al.  Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture , 1988, Nature.

[103]  D. Metcalf,et al.  The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells , 1989, Nature.

[104]  Michael J. Berridge,et al.  Inositol phosphates and cell signalling , 1989, Nature.

[105]  R. Tjian,et al.  Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. , 1989, Science.

[106]  Harold L. Moses,et al.  TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights , 1990, Cell.

[107]  A. Ullrich,et al.  p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor , 1989, Molecular and cellular biology.

[108]  A. Ashkenazi,et al.  The structural and functional interrelationships of muscarinic acetylcholine receptor subtypes , 1989, BioEssays : news and reviews in molecular, cellular and developmental biology.

[109]  D. Morrison,et al.  Direct activation of the serine/threonine kinase activity of raf-1 through tyrosine phosphorylation by the PDGF β-receptor , 1989, Cell.

[110]  T. Pawson,et al.  raf family serine/threonine protein kinases in mitogen signal transduction. , 1988, Cold Spring Harbor symposia on quantitative biology.

[111]  John D. Minna,et al.  Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer , 1985, Nature.

[112]  S. Sell Cancer markers of the 1990s. Comparison of the new generation of markers defined by monoclonal antibodies and oncogene probes to prototypic markers. , 1990, Clinics in laboratory medicine.

[113]  Robert H. Collins,et al.  Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review. , 1987, The New England journal of medicine.

[114]  J. Auwerx,et al.  IP-1: A dominant inhibitor of Fos/Jun whose activity is modulated by phosphorylation , 1991, Cell.

[115]  C. March,et al.  A new cytokine receptor superfamily. , 1990, Trends in biochemical sciences.

[116]  M. White,et al.  Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity , 1987, Cell.

[117]  M. Shibuya,et al.  Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. , 1990, Oncogene.

[118]  V. Fried,et al.  Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. , 1989, Science.

[119]  L. Cantley,et al.  Oncogenes and signal transduction , 1991, Cell.

[120]  J. Rubin,et al.  A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[121]  M. Santoro,et al.  A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases , 1987, Nature.

[122]  M. Wigler,et al.  Genetic analysis of mammalian GAP expressed in yeast , 1989, Cell.

[123]  J. Partanen,et al.  FGFR‐4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. , 1991, The EMBO journal.

[124]  C. Stiles,et al.  An ordered sequence of events is required before BALB/c-3T3 cells become committed to DNA synthesis. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[125]  J. Trimmer,et al.  Monoclonal antibody to a membrane glycoprotein inhibits the acrosome reaction and associated Ca2+ and H+ fluxes of sea urchin sperm , 1985, Cell.

[126]  M. Barbacid,et al.  The trk proto-oncogene encodes a receptor for nerve growth factor , 1991, Cell.

[127]  D. Kaplan,et al.  Induction by NGF of meiotic maturation of Xenopus oocytes expressing the trk proto-oncogene product. , 1991, Science.

[128]  J. Rubin,et al.  Expression cDNA cloning of the KGF receptor by creation of a transforming autocrine loop. , 1991, Science.

[129]  David M. Livingston,et al.  The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element , 1989, Cell.

[130]  D. Kaplan,et al.  High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor , 1991, Nature.

[131]  Robert A. Weinberg,et al.  Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies , 1985, Cell.

[132]  R. Halaban,et al.  Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes , 1988, The Journal of cell biology.

[133]  M. Santoro,et al.  PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas , 1990, Cell.

[134]  Gwyn T. Williams Programmed cell death: Apoptosis and oncogenesis , 1991, Cell.

[135]  G. Guroff,et al.  Nerve growth factor-induced alteration in the response of PC12 pheochromocytoma cells to epidermal growth factor , 1981, The Journal of cell biology.

[136]  P. Black,et al.  Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance. , 1990, The Journal of clinical investigation.

[137]  T. Pawson,et al.  Characterization of elk, a brain-specific receptor tyrosine kinase , 1991, Molecular and cellular biology.

[138]  J. Massagué,et al.  Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation , 1990, Cell.

[139]  M. Endo,et al.  Platelet-derived growth factor stimulates formation of active p21ras.GTP complex in Swiss mouse 3T3 cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[140]  G. Wasserburg,et al.  Precise Timing of the Last Interglacial Period from Mass Spectrometric Determination of Thorium-230 in Corals , 1987, Science.

[141]  M. Kris,et al.  Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer , 1991 .

[142]  R. Weinberg,et al.  The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen , 1984, Nature.

[143]  H. Hirai,et al.  A novel putative tyrosine kinase receptor encoded by the eph gene. , 1987, Science.

[144]  J. Rubin,et al.  Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. , 1991, Science.

[145]  A. Brown,et al.  ras p21 and GAP inhibit coupling of muscarinic receptors to atrial K+ channels , 1990, Cell.

[146]  W. Maltese,et al.  Isoprenylated proteins in cultured cells: Subcellular distribution and changes related to altered morphology and growth arrest induced by mevalonate deprivation , 1987, Journal of cellular physiology.

[147]  J. Avruch,et al.  Endothelin, vasopressin, and angiotensin II enhance tyrosine phosphorylation by protein kinase C-dependent and -independent pathways in glomerular mesangial cells. , 1991, The Journal of biological chemistry.

[148]  T. Libermann,et al.  Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines. , 1988, Cancer research.

[149]  L. M. Leeb-Lundberg,et al.  Bradykinin and bombesin rapidly stimulate tyrosine phosphorylation of a 120-kDa group of proteins in Swiss 3T3 cells. , 1991, The Journal of biological chemistry.

[150]  C. Heldin,et al.  Platelet-derived growth factors: A family of isoforms that bind to two disticnt receptors , 1989 .

[151]  P. Nowell,et al.  Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. , 1984, Science.

[152]  C R King,et al.  erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. , 1987, Science.

[153]  H. Lodish,et al.  Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor , 1990, Nature.

[154]  H. Varmus,et al.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. , 1984, Science.

[155]  I. Pastan,et al.  Recombinant toxins for cancer treatment. , 1991, Science.

[156]  J. Yokota,et al.  AMPLIFICATION OF c-erbB-2 ONCOGENE IN HUMAN ADENOCARCINOMAS IN VIVO , 1986, The Lancet.

[157]  R. Perlmutter,et al.  Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association , 1991, Science.

[158]  K. Miyagawa,et al.  cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[159]  S. Singer,et al.  Identification of a developmentally regulated protein-tyrosine kinase by using anti-phosphotyrosine antibodies to screen a cDNA expression library. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[160]  B. Lewin Oncogenic conversion by regulatory changes in transcription factors , 1991, Cell.

[161]  M. Roussel,et al.  Transforming potential of the c-fms proto-oncogene (CSF-1 receptor) , 1987, Nature.

[162]  H. Lodish,et al.  Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity , 1990, Nature.

[163]  B. Weissman,et al.  Interactions of growth factors and retroviral oncogenes with mitogenic signal transduction pathways of Balb/MK keratinocytes. , 1988, Oncogene.

[164]  J. Broach,et al.  The CDC25 protein of Saccharomyces cerevisiae promotes exchange of guanine nucleotides bound to ras , 1991, Molecular and cellular biology.

[165]  Y Nishizuka,et al.  The protein kinase C family: heterogeneity and its implications. , 1989, Annual review of biochemistry.

[166]  J. Shepherd,et al.  REGRESSION OF LIVER METASTASES IN PATIENT WITH GASTRIN-SECRETING TUMOUR TREATED WITH SMS 201-995 , 1986, The Lancet.

[167]  D. Morrison,et al.  Signal transduction from membrane to cytoplasm: growth factors and membrane-bound oncogene products increase Raf-1 phosphorylation and associated protein kinase activity. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[168]  H. Lodish,et al.  Cloning and functional expression of a vascular smooth muscle endothelin 1 receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[169]  T. Hunter,et al.  The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor , 1991, Cell.

[170]  Y. Tsujimoto,et al.  Involvement of the bcl-2 gene in human follicular lymphoma. , 1985, Science.

[171]  T. Fleming,et al.  Development of a highly efficient expression cDNA cloning system: application to oncogene isolation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[172]  L. Cantley,et al.  Phosphatidylinositol metabolism and polyoma-mediated transformation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[173]  A. Ullrich,et al.  Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors , 1986, Nature.

[174]  G. Wogan,et al.  The TPR-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[175]  E. Kawasaki,et al.  Two G protein oncogenes in human endocrine tumors. , 1990, Science.

[176]  Jonathan A. Cooper,et al.  Binding of GAP to activated PDGF receptors. , 1990, Science.

[177]  S. Courtneidge,et al.  Association between the PDGF receptor and members of the src family of tyrosine kinases , 1990, Cell.

[178]  W. Schafer,et al.  Genetic and pharmacological suppression of oncogenic mutations in ras genes of yeast and humans. , 1989, Science.

[179]  A. Burgess,et al.  Hierarchical down-modulation of hemopoietic growth factor receptors , 1985, Cell.

[180]  R. Weinberg The retinoblastoma gene and cell growth control. , 1990, Trends in biochemical sciences.

[181]  R. Weinberg,et al.  Identification of a nucleotide exchange-promoting activity for p21ras. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[182]  C. Stiles,et al.  Induction of DNA synthesis in BALB/c 3T3 cells by serum components: reevaluation of the commitment process. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[183]  P. Worley,et al.  Muscarinic agonists and phorbol esters increase tyrosine phosphorylation of a 40-kilodalton protein in hippocampal slices. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[184]  K. Semba A v-erbB-related protooncogene, c-erb-B-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma , 1985 .

[185]  J. Rowley,et al.  The human met oncogene is related to the tyrosine kinase oncogenes , 1985, Nature.

[186]  I. Pastan,et al.  Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene. , 1987, Science.

[187]  J Vandekerckhove,et al.  Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells , 1990, The Journal of cell biology.

[188]  D. Morrison,et al.  PDGF β-receptor stimulates tyrosine phosphorylation of GAP and association of GAP with a signaling complex , 1990, Cell.

[189]  H. Bourne,et al.  GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumours , 1989, Nature.

[190]  T Pawson,et al.  SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. , 1991, Science.

[191]  W. Pledger,et al.  Epidermal growth factor (EGF) and somatomedin C regulate G1 progression in competent BALB/c-3T3 cells. , 1982, Experimental cell research.

[192]  M. Caron,et al.  Structure of the adrenergic and related receptors. , 1989, Annual review of neuroscience.

[193]  John E. Murphy,et al.  A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family , 1986, Nature.

[194]  K. Tashiro,et al.  Molecular cloning and expression of human hepatocyte growth factor , 1989, Nature.

[195]  M. Nakafuku,et al.  Involvement of ras p21 protein in signal-transduction pathways from interleukin 2, interleukin 3, and granulocyte/macrophage colony-stimulating factor, but not from interleukin 4. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[196]  G. Peters,et al.  The structure and function of the int-2 oncogene. , 1989, Progress in growth factor research.

[197]  A. Ullrich,et al.  Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[198]  W. Haser,et al.  Raf-1: A kinase currently without a cause but not lacking in effects , 1991, Cell.

[199]  J. Gil,et al.  Bombesin, vasopressin, and endothelin rapidly stimulate tyrosine phosphorylation in intact Swiss 3T3 cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[200]  R F Doolittle,et al.  Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. , 1983, Science.

[201]  A. Schally,et al.  Antitumor Effects of Analogs of Hypothalamic Hormones in Endocrine-Dependent Cancers , 1984, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[202]  G. Labourdette,et al.  Effects of acidic and basic fibroblast growth factors on proliferation and maturation of cultured rat oligodendrocytes , 1989, International Journal of Developmental Neuroscience.

[203]  T. Nakamura,et al.  Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[204]  G. Michalopoulos,et al.  Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. , 1991, Oncogene.

[205]  B. Gliniak,et al.  Expression of the M-CSF receptor is controlled posttranscriptionally by the dominant actions of GM-CSF or multi-CSF , 1990, Cell.

[206]  Paul Stroobant,et al.  Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus , 1983, Nature.

[207]  C. Heldin,et al.  Similar action of platelet‐derived growth factor and epidermal growth factor in the prereplicative phase of human fibroblasts suggests a common intracellular pathway , 1985, Journal of cellular physiology.

[208]  A. Pardee G1 events and regulation of cell proliferation. , 1989, Science.

[209]  V. Fried,et al.  cDNA cloning of a Novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF β-receptor , 1991, Cell.

[210]  T. Hunter,et al.  cDNA cloning and characterization of eck, an epithelial cell receptor protein-tyrosine kinase in the eph/elk family of protein kinases , 1990, Molecular and cellular biology.

[211]  J. Rubin,et al.  Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. , 1989, Science.